Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA)
- 17 September 2010
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 68 (5), 611-618
- https://doi.org/10.1002/ana.22122
Abstract
Objective Neurodegeneration with brain iron accumulation (NBIA) represents a distinctive phenotype of neurodegenerative disease for which several causative genes have been identified. The spectrum of neurologic disease associated with mutations in NBIA genes is broad, with phenotypes that range from infantile neurodegeneration and death in childhood to adult‐onset parkinsonism‐dystonia. Here we report the discovery of a novel gene that leads to a distinct form of NBIA. Methods Using autozygosity mapping and candidate gene sequencing, we identified mutations in the fatty acid hydroxylase gene FA2H, newly implicating abnormalities of ceramide metabolism in the pathogenesis of NBIA. Results Neuroimaging demonstrated T2 hypointensity in the globus pallidus, confluent T2 white matter hyperintensities, and profound pontocerebellar atrophy in affected members of two families. Phenotypically, affected family members exhibited spastic quadriparesis, ataxia, and dystonia with onset in childhood and episodic neurological decline. Analogous to what has been reported previously for PLA2G6, the phenotypic spectrum of FA2H mutations is diverse based on our findings and those of prior investigators, because FA2H mutations have been identified in both a form of hereditary spastic paraplegia (SPG35) and a progressive familial leukodystrophy. Interpretation These findings link white matter degeneration and NBIA for the first time and implicate new signaling pathways in the genesis of NBIA. ANN NEUROL 2010This publication has 35 references indexed in Scilit:
- Fatty acid 2-Hydroxylation in mammalian sphingolipid biologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Layer-specific variation of iron content in cerebral cortex as a source of MRI contrastProceedings of the National Academy of Sciences of the United States of America, 2010
- Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T Schwannoma cellsJournal of Lipid Research, 2009
- Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and deathJournal of the Neurological Sciences, 2009
- α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityNature Genetics, 2009
- Mutations in the Fatty Acid 2-Hydroxylase Gene Are Associated with Leukodystrophy with Spastic Paraparesis and DystoniaAmerican Journal of Human Genetics, 2008
- Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body diseaseThe FEBS Journal, 2008
- Clinical and genetic delineation of neurodegeneration with brain iron accumulationJournal of Medical Genetics, 2008
- Neurodegeneration associated with genetic defects in phospholipase A 2Neurology, 2008
- PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain ironNature Genetics, 2006